REGN stock upgraded at JPMorgan on upcoming catalysts (NASDAQ:REGN)

Wall street sign in New York with New York Stock Exchange background

naphtalina/iStock by way of Getty Images

Regeneron (NASDAQ:REGN) shares trended greater pre-market Friday after JPMorgan upgraded the stock to Overweight from Neutral, noting a number of key catalysts in 2023, together with the upcoming launch of high-dose Eylea.

Citing the corporate’s early earnings outcomes, JPMorganOTCQX:RHHBYOTCQX:RHHBF

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!